v3.25.4
Insider Trading Arrangements
 3 Months Ended
Dec. 31, 2025
shares
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement

Trading Arrangements

During the fiscal quarter ended December 31, 2025, our directors and officers (as defined in Rule 16a-1(f) under the Exchange Act) adopted or terminated the contracts, instructions or written plans for the purchase or sale of the Company’s securities set forth in the table below:

 

 

 

 

Type of Trading Arrangement

 

 

Name and Position

Action

Adoption / Termination Date

Rule 10b5-1*

Non-Rule 10b5-1**

Total Shares of Common Stock to be Sold

Expiration Date

Fred Aslan, M.D. (President, Chief Executive Officer and Director)

Termination1

December 29, 2025

X

 

471,558

December 31, 2026

Jennifer Bush (Chief Operating Officer, Chief Legal Officer and Compliance Officer)

Termination2

December 22, 2025

X

 

28,000

May 31, 2026

Christopher Horan (Chief Technical Operations Officer)

Termination3

December 15, 2025

X

 

44,200

April 15, 2026

Heather Raymon (Senior Vice President of Research and Early Development)

Termination4

December 15, 2025

X

 

25,434

April 15, 2026

* Contract, instruction or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act.

** “Non-Rule 10b5-1 trading arrangement” as defined in Item 408(c) of Regulation S-K under the Exchange Act.

 

1 Represents the termination of a written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) adopted on July 23, 2024.

2 Represents the termination of a written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) adopted on July 23, 2024.

3 Represents the termination of a written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) adopted on July 23, 2024.

4 Represents the termination of a written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) adopted on July 23, 2024.

 

 
Fred Aslan M.D [Member]  
Trading Arrangements, by Individual  
Name Fred Aslan, M.D.
Title President, Chief Executive Officer and Director
Rule 10b5-1 Arrangement Terminated true
Termination Date December 29, 2025
Expiration Date December 31, 2026
Aggregate Available 471,558
Jennifer Bush [Member]  
Trading Arrangements, by Individual  
Name Jennifer Bush
Title Chief Operating Officer, Chief Legal Officer and Compliance Officer
Rule 10b5-1 Arrangement Terminated true
Termination Date December 22, 2025
Expiration Date May 31, 2026
Aggregate Available 28,000
Christopher Horan [Member]  
Trading Arrangements, by Individual  
Name Christopher Horan
Title Chief Technical Operations Officer
Rule 10b5-1 Arrangement Terminated true
Termination Date December 15, 2025
Expiration Date April 15, 2026
Aggregate Available 44,200
Heather Raymon [Member]  
Trading Arrangements, by Individual  
Name Heather Raymon
Title Senior Vice President of Research and Early Development
Rule 10b5-1 Arrangement Terminated true
Termination Date December 15, 2025
Expiration Date April 15, 2026
Aggregate Available 25,434